NCT00610454View on ClinicalTrials.gov

Safety and Tolerability of Levetiracetam Intravenous 15 Minute Infusion in Subjects Suffering From Partial Onset Seizures

PHASE2CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

June 30, 2004

Primary Completion Date

August 31, 2004

Study Completion Date

August 31, 2004

Conditions
Epilepsy
Interventions
DRUG

Levetiracetam

Sponsors

Lead Sponsor

UCB Pharma
All Listed Sponsors
lead

UCB Pharma

INDUSTRY